Clinical trial INCB59872-101

A Phase 1/2, Open-Label, Dose-Escalation / Dose-Expansion, Safety and Tolerability Study of INCB059872 in Subjects With Advanced Malignancies

Cancers	Lung and thorax cancers Breast cancers Blood cell cancers Skin cancers Head and neck cancers Gynaecological cancers Liver cancers Digestive cancers Colorectal cancers
Organ	Solid tumors
Trial status	Trial closed
Trial type	Interventional with experimental drug
Phase	Trial phase 1/2
Academic trial	Non
Sponsor	Incyte Corporate
EudraCT Identifier	2017-001710-28
ClinicalTrials.gov	https://clinicaltrials.gov/ct2/show/NCT02712905
Inclusion criteria	Any line
Last update	21/04/2022